Missouri drugmaker latest to recall metformin over carcinogen

(By Maia Anderson for Becker’s Hospital Review)

A Kansas City, Mo.-based drugmaker, Nostrum Laboratories, has become the latest company to recall its diabetes drug, metformin, after finding it contains unacceptably high levels of a carcinogen.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org